EW vs. VEEV: Edwards Lifesciences vs. Veeva Systems Stock Comparison
How do Edwards Lifesciences (EW) and Veeva Systems (VEEV) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Edwards Lifesciences (EW) and Veeva Systems (VEEV) both fall under the Health Care Equipment & Services industry group, but EW is classified in Health Care Equipment & Supplies while VEEV is classified in Health Care Technology.
| Profile Item | EW | VEEV |
|---|---|---|
| Name | Edwards Lifesciences Corporation | Veeva Systems Inc. |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Technology |
| GICS Sub-Industry | Health Care Equipment | Health Care Technology |
| Market Capitalization | 58.73 billion USD | 49.18 billion USD |
| Currency | USD | USD |
| Exchange | NYSE | NYSE |
| Listing Date | March 27, 2000 | October 16, 2013 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | EW | VEEV |
|---|---|---|
| Total Return (1Y) | 25.08% | 3.92% |
| Total Return (3Y, Annualized) | 17.28% | 22.52% |
| Total Return (5Y, Annualized) | -2.77% | -0.87% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | EW | VEEV |
|---|---|---|
| Volatility (1Y, Annualized) | 25.58% | 43.36% |
| Beta (5Y) | 0.78 | 0.88 |
| Max Drawdown (5Y) | -54.32% | -52.79% |
| Avg. Volume (3M) | 3.69M | 1.64M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | EW | VEEV |
|---|---|---|
| Sharpe Ratio (1Y) | 0.81 | -0.01 |
| Sortino Ratio (1Y) | 1.23 | -0.01 |
Profitability
ROE (TTM)
Veeva Systems (VEEV) at 14.43% sits in the top ROE quartile, while Edwards Lifesciences (EW) at 9.33% is closer to the peer norm — stronger capital efficiency for VEEV.
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
VEEV
Health Care Equipment & Services industry group
14.43%
- Max
- 47.61%
- VEEV
- 14.43%
- Q3
- 14.36%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Edwards Lifesciences (EW) at 15.30% and Veeva Systems (VEEV) at 29.35% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
VEEV
Health Care Equipment & Services industry group
29.35%
- VEEV
- 29.35%
- Max
- 29.35%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Edwards Lifesciences (EW) at 30.15% and Veeva Systems (VEEV) at 29.64% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
VEEV
Health Care Equipment & Services industry group
29.64%
- Max
- 35.43%
- VEEV
- 29.64%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | EW | VEEV |
|---|---|---|
| ROE (TTM) | 9.33% | 14.43% |
| ROA (TTM) | 8.77% | 7.58% |
| Net Margin (TTM) | 15.30% | 29.35% |
| Operating Margin (TTM) | 30.15% | 29.64% |
| Gross Margin (TTM) | 78.02% | 74.96% |
Growth
Revenue Growth
Both Edwards Lifesciences (EW) at 11.55% and Veeva Systems (VEEV) at 16.34% land near their industries' usual revenue growth ranges, so top-line momentum looks broadly in line with peers on both sides.
EPS Growth
Veeva Systems (VEEV) at 25.93% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | EW | VEEV |
|---|---|---|
| Revenue Growth (YoY) | 11.55% | 16.34% |
| Revenue Growth (3Y CAGR) | 10.77% | 14.03% |
| EPS Growth (YoY) | -73.74% | 25.93% |
| EPS Growth (3Y CAGR) | -9.14% | 21.94% |
Financial Strength
Current Ratio (MRQ)
Both Edwards Lifesciences (EW) at 4.60 and Veeva Systems (VEEV) at 5.46 post current ratio above their industries’ typical mid-ranges — short-term liquidity appears comfortable, though unusually high readings can point to idle current assets.
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
VEEV
Health Care Equipment & Services industry group
5.46
- Max
- 7.59
- VEEV
- 5.46
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Edwards Lifesciences (EW) at 0.06 and Veeva Systems (VEEV) at 0.02 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
VEEV
Health Care Equipment & Services industry group
0.02
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- VEEV
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | EW | VEEV |
|---|---|---|
| Current Ratio (MRQ) | 4.60 | 5.46 |
| Debt / Equity (MRQ) | 0.06 | 0.02 |
| Net Debt / EBITDA | -1.88 | -6.59 |
Dividends
Dividend Yield (TTM)
Neither Edwards Lifesciences (EW) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
VEEV
Health Care Equipment & Services industry group
0.00%
- VEEV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Edwards Lifesciences (EW) nor Veeva Systems (VEEV) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
VEEV
Health Care Equipment & Services industry group
0.00%
- VEEV
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | EW | VEEV |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Both Edwards Lifesciences (EW) at 59.38 and Veeva Systems (VEEV) at 49.79 sit in the richer earnings-multiple quartile for P/E ratio, so investors are paying more for TTM earnings than they pay for typical peers.
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
VEEV
Health Care Equipment & Services industry group
49.79
- Max
- 80.41
- VEEV
- 49.79
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Both look expensive on sales: Edwards Lifesciences (EW) at 8.80 sits in the upper P/S ratio quartile, and Veeva Systems (VEEV) at 14.22 prices even higher, above its industry range.
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
VEEV
Health Care Equipment & Services industry group
14.22
- VEEV
- 14.22
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
Edwards Lifesciences (EW) at 5.41 is valued about in line with its industry on P/B ratio, while Veeva Systems (VEEV) at 6.61 carries an above-peer premium to book — VEEV is pricier on assets.
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
VEEV
Health Care Equipment & Services industry group
6.61
- Max
- 11.68
- VEEV
- 6.61
- Q3
- 6.12
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | EW | VEEV |
|---|---|---|
| P/E Ratio (TTM) | 59.38 | 49.79 |
| P/S Ratio (TTM) | 8.80 | 14.22 |
| P/B Ratio (MRQ) | 5.41 | 6.61 |
| Free Cash Flow Yield (TTM) | 1.95% | 2.56% |